Allergy Workflows Are Where This Has to Earn Its Keep
Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not whether AI sounds futuristic, but whether it removes real friction from specialty practice work.
ModuleMD has spent more than 25 years building technology around allergy and immunology practices, according to the company. Its latest pitch is WISE Touch AI, a redesigned EHR experience that puts AI-assisted documentation, clinical decision support, and CPT suggestions nearer to the point of care. The company is also tying together automated skin testing, conversational data access, and front-office automation. On paper, that is a sensible place to aim. Specialty medicine is littered with general-purpose software that claims to fit everybody and winds up fitting nobody particularly well.
One Platform Beats a Pile of Add-Ons
The most interesting part is not one flashy feature. It is ModuleMD's attempt to make clinical notes, scheduling, eligibility checks, authorizations, referrals, revenue-cycle work, immunotherapy, biologics, and infusion management behave like parts of the same operation. In allergy care, those functions are tangled together whether vendors like it or not.
ModuleMD Front Desk uses five specialized AI agents across intake, scheduling, insurance eligibility and estimates, authorizations, and referrals, overseen by a supervisor agent. That is ambitious, and frankly it should be judged with a hard eye. Front-office tasks are repetitive, but they are not trivial. A bad insurance estimate or a missed authorization is not merely an annoying software bug; it can create staff headaches, patient confusion, and payment problems. Automation has value only when practices can trust the handoff and readily catch exceptions.
ModuleMDQ, the company's conversational practice-intelligence tool, takes a different route. Teams can ask questions of practice data in natural language rather than hunt across screens. If it delivers reliable answers with proper context, that could save time. If it returns vague or poorly grounded answers, it becomes one more thing staff must double-check. Healthcare has no shortage of systems that promise simplicity while quietly adding another verification step.
SkinSight Targets a Real, Narrow Pain Point
SkinSight is probably the clearest example of the company's specialty-first argument. Skin testing requires measurement and documentation of wheal and flare reactions, work that can be repetitive and manual. ModuleMD says its image-based AI can use images taken with a device already available to the practice, detect and measure reactions, and place structured results plus timestamped images directly into the patient chart.
That is not glamorous. Good. The best healthcare technology often is not glamorous. It handles a routine task accurately, preserves the documentation trail, and gives clinicians room to review and interpret the result. The stated support for documentation associated with CPT 95004 also shows ModuleMD understands that clinical workflow and billing workflow cannot be treated as separate planets.
AI in a specialty practice is useful when it disappears into the job, not when it demands applause for showing up.
Still, the company has not provided performance metrics, error rates, deployment figures, or independent validation in these notes. Those are not minor details. Image-based measurement tools need clinician confidence, clear review processes, and dependable integration before a practice should lean on them heavily. Investors watching healthcare technology should resist filling in those blanks with wishful thinking.
Client Interest Is Encouraging, Not a Scorecard
ModuleMD reports considerable interest and positive feedback from existing clients after its WISE Touch first-look webinar. That is encouraging, especially for a platform built around a defined specialty. Existing customers are the people who know where the old workflow hurts. If they see a cleaner path, that matters.
But “strong interest” is a soft signal, not a revenue figure or adoption rate. There is no disclosure here on signed upgrades, retention, pricing, implementation time, or measurable reductions in documentation burden. Those are the numbers that separate a compelling conference demonstration from a durable product cycle. The healthcare-software graveyard is full of features people liked in demos and never fully used on Tuesday morning.
The Real Test Comes After the Booth Lights Go Down
ModuleMD's ACAAI 2026 showing makes a coherent case that allergy practices deserve purpose-built AI rather than a generic EHR with a few specialty labels pasted on top. WISE Touch AI, JOSH conversational documentation in more than 75 languages, SkinSight, Front Desk, and ModuleMDQ all point toward a connected operating model.
The next chapter is execution: safe rollout, staff acceptance, reliable outputs, integration without disruption, and proof that the system genuinely saves time. If ModuleMD can show those outcomes, its allergy focus could be a meaningful advantage. If not, it is just another vendor saying “AI” loudly in a crowded hall. The distinction will be made in the clinic, one ordinary patient encounter at a time.